Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
Clinical trial NCT03691610 · COMPLETED
Trial details
- NCT number
- NCT03691610
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-04
- Primary completion
- 2023-10-20
- Enrollment
- 950
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.